Buy Top Purity Cabozantinib Malate

English name: Cabozantinib Malate
Synonyms: (2S) -2-Hydroxybutanedioic acid compd. With N- [4 - [(6,7-dimethoxy-4-quinolinyl) oxy] phenyl] -N '- (4-fluorophenyl) -1,1-cyclopropanedicarboxamide (1: 1); Cabozantinib (S) -malate; Cabozantinib L-Malate Salt
CAS Number: 1140909-48-3
Molecular formula: C32H30FN3O10
Molecular weight: 635.5931032
EINECS number:
Related categories: protein tyrosine kinase; small molecule inhibitors; Inhibitors; small molecule inhibitors, natural products; anti-thyroid medullary carcinoma; pharmaceutical raw materials;
Mol file: 1140909-48-3.mol

Description of Cabozantinib Malate 

Cabozantinib malate is a potent inhibitor of MET andVEGF receptor2 with IC50 values of 1.3nM and 0.035nM.
Cabozantinib is a pan-tyrosine kinase inhibitor and is developed as an oral treatment of various cancers including MTC, GBM, NSCLC, pancreatic carcinoma, breast and colon cancer. The targets of cabozantinib are MET, VEGFR-2, RET, FLT3, KIT, AXL as well as TEK. In cellular assays, cabozantinib inhibits the phosphorylation of MET, VEGFR2, KIT, FLT3 and AXL .
 
Cabozantinib Malate Pharmacological Effects

 The drug is mainly targeted at MET and VEGFR2 tyrosine kinases that associated with the growth and proliferation of prostate cancer, inhibiting tumor metastasis and angiogenesis. Cabozantinib S-MALATE , the malate of Cabozantinib, is an effective VEGFR2 inhibitor, and IC50 is 0.035 nM. It also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2 and AXL, and IC50 is 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM respectively.

 And advanced renal cell carcinoma in people who have received prior anti-angiogenic therapy. It is currently undergoing clinical trials for the treatment of prostate, bladder, ovarian, brain, melanoma, breast, non-small cell lung, pancreatic, and hepatocellular cancers.

Cabozantinib (S)-malate salt is a white to off-white solid that is practically insoluble in aqueous media.
 
Our Advantage
 




  English name: Cabozantinib Malate
Synonyms: (2S) -2-Hydroxybutanedioic acid compd. With N- [4 - [(6,7-dimethoxy-4-quinolinyl) oxy] phenyl] -N '- (4-fluorophenyl) -1,1-cyclopropanedicarboxamide (1: 1); Cabozantinib (S) -malate; Cabozantinib L-Malate Salt
CAS Number: 1140909-48-3
Molecular formula: C32H30FN3O10
Molecular weight: 635.5931032
EINECS number:
Related categories: protein tyrosine kinase; small molecule inhibitors; Inhibitors; small molecule inhibitors, natural products; anti-thyroid medullary carcinoma; pharmaceutical raw materials;
Mol file: 1140909-48-3.mol

Description of Cabozantinib Malate 

Cabozantinib malate is a potent inhibitor of MET andVEGF receptor2 with IC50 values of 1.3nM and 0.035nM.
Cabozantinib is a pan-tyrosine kinase inhibitor and is developed as an oral treatment of various cancers including MTC, GBM, NSCLC, pancreatic carcinoma, breast and colon cancer. The targets of cabozantinib are MET, VEGFR-2, RET, FLT3, KIT, AXL as well as TEK. In cellular assays, cabozantinib inhibits the phosphorylation of MET, VEGFR2, KIT, FLT3 and AXL .
 
Cabozantinib Malate Pharmacological Effects

 The drug is mainly targeted at MET and VEGFR2 tyrosine kinases that associated with the growth and proliferation of prostate cancer, inhibiting tumor metastasis and angiogenesis. Cabozantinib S-MALATE , the malate of Cabozantinib, is an effective VEGFR2 inhibitor, and IC50 is 0.035 nM. It also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2 and AXL, and IC50 is 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM respectively.

 And advanced renal cell carcinoma in people who have received prior anti-angiogenic therapy. It is currently undergoing clinical trials for the treatment of prostate, bladder, ovarian, brain, melanoma, breast, non-small cell lung, pancreatic, and hepatocellular cancers.

Cabozantinib (S)-malate salt is a white to off-white solid that is practically insoluble in aqueous media.
 
Our Advantage
 




 

Some products, such as softgel, hard capsule, tablets etc. we have our own Strategic cooperation factory, who can produce OEM products depending on customers requiremens.

Hot producs:

CLA softgel

Fish Oil softgel

Krill oil softgel

Astaxanthin softgel

Empty hard capsule(HPMC, gelatin etc.)

tablets (Multivitamins, Mullti-plant etc.)

Softgels are widely used in prescription and OTC pharmaceuticals, as well as nutraceuticals for their improved bioavailability, ease of swallowing, positive consumer response, reduced odors/flavors, extended shelf life and flexible product formulation options.

Depending upon the production criteria, the gelatin shell may include minor additives such as coloring agents, flavors, sweeteners, preservatives and even various medicines. Enteric coating is now available for softgel capsules for certain applications where delivery of the active substance should bypass gastric juices in the stomach to be absorbed in the intestinal tract. For example, fish oil, garlic, peppermint oil and oregano oil are examples of enteric coated nutritional products. The coating helps mask unpleasant odors and tastes, and prevents irritation of the stomach lining.

Hard gelatin capsules are a preferred oral dosage form in pharmaceutical and nutritional applications as they are neutral in taste and very easy to swallow.

We specialize in high performance tablet products including controlled/time release solid dose products. Inovobiologic`s scientists are equipped to offer accelerated new product development and provide consultation.

Contract manufacturing

Soft Capsule,Vitamin E Softgel,Multi-Plants Extracts Softgel,Vitamin Softgel

Excellent Health Products Co.,Ltd. , http://www.sino-excellent.com